Home Healthcare Pharmaceuticals Tuberculosis Drugs Market

Tuberculosis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Isoniazid, Rifampin, Ethambutol, Pyrazinamide, Fluoroquinolones, Bedaquiline, Pretomanid, Delamanid, Aminoglycosides, Thioamides, Cyclic Peptides, Other Drug Classes), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies, Other Distribution Channels) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 02, 2026 | Author: Debashree B | Format: | Report Code: SR168DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Tuberculosis Drugs Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Isoniazid
    2. Rifampin
    3. Ethambutol
    4. Pyrazinamide
    5. Fluoroquinolones
    6. Bedaquiline
    7. Pretomanid
    8. Delamanid
    9. Aminoglycosides
    10. Thioamides
    11. Cyclic Peptides
    12. Other Drug Classes
  2. Tuberculosis Drugs Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
    4. Other Distribution Channels
  3. Regional Tuberculosis Drugs Market
    1. North America
      1. North America Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      2. North America Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
      3. U.S. Tuberculosis Drugs Market
        1. U.S. Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. U.S. Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      4. Canada Tuberculosis Drugs Market
        1. Canada Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Canada Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
    2. Europe
      1. Europe Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      2. Europe Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
      3. U.K. Tuberculosis Drugs Market
        1. U.K. Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. U.K. Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      4. Germany Tuberculosis Drugs Market
        1. Germany Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Germany Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      5. France Tuberculosis Drugs Market
        1. France Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. France Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      6. Spain Tuberculosis Drugs Market
        1. Spain Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Spain Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      7. Italy Tuberculosis Drugs Market
        1. Italy Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Italy Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      8. Russia Tuberculosis Drugs Market
        1. Russia Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Russia Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      9. Nordic Tuberculosis Drugs Market
        1. Nordic Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Nordic Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      10. Benelux Tuberculosis Drugs Market
        1. Benelux Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Benelux Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      11. Rest of Europe Tuberculosis Drugs Market
        1. Rest of Europe Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Rest of Europe Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
    3. APAC
      1. APAC Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      2. APAC Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
      3. China Tuberculosis Drugs Market
        1. China Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. China Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      4. Korea Tuberculosis Drugs Market
        1. Korea Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Korea Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      5. Japan Tuberculosis Drugs Market
        1. Japan Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Japan Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      6. India Tuberculosis Drugs Market
        1. India Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. India Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      7. Australia Tuberculosis Drugs Market
        1. Australia Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Australia Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      8. Singapore Tuberculosis Drugs Market
        1. Singapore Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Singapore Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      9. Taiwan Tuberculosis Drugs Market
        1. Taiwan Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Taiwan Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      10. South East Asia Tuberculosis Drugs Market
        1. South East Asia Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. South East Asia Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      11. Rest of Asia-Pacific Tuberculosis Drugs Market
        1. Rest of Asia-Pacific Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Rest of Asia-Pacific Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
    4. Middle East and Africa
      1. Middle East and Africa Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      2. Middle East and Africa Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
      3. UAE Tuberculosis Drugs Market
        1. UAE Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. UAE Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      4. Turkey Tuberculosis Drugs Market
        1. Turkey Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Turkey Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      5. Saudi Arabia Tuberculosis Drugs Market
        1. Saudi Arabia Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Saudi Arabia Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      6. South Africa Tuberculosis Drugs Market
        1. South Africa Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. South Africa Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      7. Egypt Tuberculosis Drugs Market
        1. Egypt Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Egypt Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      8. Nigeria Tuberculosis Drugs Market
        1. Nigeria Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Nigeria Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      9. Rest of MEA Tuberculosis Drugs Market
        1. Rest of MEA Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Rest of MEA Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
    5. LATAM
      1. LATAM Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Isoniazid
        2. Rifampin
        3. Ethambutol
        4. Pyrazinamide
        5. Fluoroquinolones
        6. Bedaquiline
        7. Pretomanid
        8. Delamanid
        9. Aminoglycosides
        10. Thioamides
        11. Cyclic Peptides
        12. Other Drug Classes
      2. LATAM Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
        4. Other Distribution Channels
      3. Brazil Tuberculosis Drugs Market
        1. Brazil Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Brazil Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      4. Mexico Tuberculosis Drugs Market
        1. Mexico Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Mexico Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      5. Argentina Tuberculosis Drugs Market
        1. Argentina Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Argentina Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      6. Chile Tuberculosis Drugs Market
        1. Chile Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Chile Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      7. Colombia Tuberculosis Drugs Market
        1. Colombia Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Colombia Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
      8. Rest of LATAM Tuberculosis Drugs Market
        1. Rest of LATAM Tuberculosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Isoniazid
          2. Rifampin
          3. Ethambutol
          4. Pyrazinamide
          5. Fluoroquinolones
          6. Bedaquiline
          7. Pretomanid
          8. Delamanid
          9. Aminoglycosides
          10. Thioamides
          11. Cyclic Peptides
          12. Other Drug Classes
        2. Rest of LATAM Tuberculosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Online Pharmacies
          4. Other Distribution Channels
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.